Targeted Delivery of Epidermal Growth Factor to the Human Placenta to Treat Fetal Growth Restriction

Placental dysfunction is the underlying cause of pregnancy complications such as fetal growth restriction (FGR) and pre-eclampsia. No therapies are available to treat a poorly functioning placenta, primarily due to the risks of adverse side effects in both the mother and the fetus resulting from sys...

Descripción completa

Detalles Bibliográficos
Autores principales: Renshall, Lewis J., Beards, Frances, Evangelinos, Angelos, Greenwood, Susan L., Brownbill, Paul, Stevens, Adam, Sibley, Colin P., Aplin, John D., Johnstone, Edward D., Teesalu, Tambet, Harris, Lynda K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618188/
https://www.ncbi.nlm.nih.gov/pubmed/34834193
http://dx.doi.org/10.3390/pharmaceutics13111778

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618188/
https://www.ncbi.nlm.nih.gov/pubmed/34834193
http://dx.doi.org/10.3390/pharmaceutics13111778

Ejemplares similares